New aspects of natural-killer-cell surveillance and therapy of cancer (Q34988265)

5 August 2017

1 reference

title

New aspects of natural-killer-cell surveillance and therapy of cancer (English)

1 reference

5 August 2017

Mark J Smyth

1

0 references

Hideo Yagita

series ordinal

4

object named as

Hideo Yagita

1 reference

5 August 2017

Yoshihiro Hayakawa

2

1 reference

5 August 2017

Kazuyoshi Takeda

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

Nature Reviews Cancer

1 reference

5 August 2017

2

1 reference

5 August 2017

11

1 reference

5 August 2017

850-861

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc928

5 August 2017

0 references

cites work

Natural killer cells, viruses and cancer

1 reference

Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver

21 January 2018

1 reference

Activation and function of natural killer cell responses during viral infections

21 January 2018

1 reference

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

21 January 2018

1 reference

The biology of human natural killer-cell subsets

21 January 2018

1 reference

Natural killer cell activation in mice and men: different triggers for similar weapons?

21 January 2018

1 reference

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

21 January 2018

1 reference

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

21 January 2018

1 reference

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

Perforin dependence of natural killer cell-mediated tumor control in vivo

21 January 2018

1 reference

An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum

21 January 2018

1 reference

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

21 January 2018

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

Differential tumor surveillance by natural killer (NK) and NKT cells.

21 January 2018

1 reference

Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice

21 January 2018

1 reference

Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A (XPA) model mice

21 January 2018

1 reference

Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum

21 January 2018

1 reference

Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.

21 January 2018

1 reference

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

21 January 2018

1 reference

Decreased tumor surveillance in perforin-deficient mice

21 January 2018

1 reference

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

21 January 2018

1 reference

Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity

21 January 2018

1 reference

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

21 January 2018

1 reference

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

21 January 2018

1 reference

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

21 January 2018

1 reference

A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells

21 January 2018

1 reference

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

21 January 2018

1 reference

Signal transduction during natural killer cell activation: inside the mind of a killer

21 January 2018

1 reference

A family of murine NK cell receptors specific for target cell MHC class I molecules

21 January 2018

1 reference

The Ly-49 family: genes, proteins and recognition of class I MHC.

21 January 2018

1 reference

21 January 2018

1 reference

Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

21 January 2018

1 reference

Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumour cells

21 January 2018

1 reference

MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity

21 January 2018

1 reference

Cellular therapy: exploiting NK cell alloreactivity in transplantation

21 January 2018

1 reference

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

Genetic control of natural killing and in vivo tumor elimination by the Chok locus

21 January 2018

1 reference

The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing

21 January 2018

1 reference

Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases

21 January 2018

1 reference

CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.

21 January 2018

1 reference

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

On guard--activating NK cell receptors

21 January 2018

1 reference

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

21 January 2018

1 reference

Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.

21 January 2018

1 reference

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

An activating immunoreceptor complex formed by NKG2D and DAP10

21 January 2018

1 reference

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

21 January 2018

1 reference

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

21 January 2018

1 reference

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

21 January 2018

1 reference

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

21 January 2018

1 reference

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

21 January 2018

1 reference

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

MICA gene polymorphism is not associated with an increased risk for skin cancer

21 January 2018

1 reference

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo

21 January 2018

1 reference

Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.

21 January 2018

1 reference

Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation

21 January 2018

1 reference

Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome

21 January 2018

1 reference

Interleukin 15: biology and relevance to human disease

21 January 2018

1 reference

Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response.

21 January 2018

1 reference

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

21 January 2018

1 reference

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

21 January 2018

1 reference

Fractalkine-mediated endothelial cell injury by NK cells

21 January 2018

1 reference

Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression

21 January 2018

1 reference

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

21 January 2018

1 reference

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

Induction of sensitivity to NK-mediated cytotoxicity by TNF-alpha treatment: possible role of ICAM-3 and CD44.

21 January 2018

1 reference

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.

21 January 2018

1 reference

A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma

21 January 2018

1 reference

Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma.

21 January 2018

1 reference

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

21 January 2018

1 reference

Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells

21 January 2018

1 reference

Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92

21 January 2018

1 reference

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

In vivo natural reactivity of mice against tumor cells

21 January 2018

1 reference

Interleukin-12: a cytokine at the interface of inflammation and immunity

31 March 2020

1 reference

Immunodeficiency states and related malignancies.

31 March 2020

1 reference

B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth

31 March 2020

1 reference

Impairment of Natural-Killer-Cell Activity in Xeroderma Pigmentosum

31 March 2020

1 reference

Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12

31 March 2020

1 reference

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

31 March 2020

1 reference

The unconventional lifestyle of NKT cells

31 March 2020

1 reference

Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells

31 March 2020

1 reference

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

31 March 2020

1 reference

Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo

31 March 2020

1 reference

Comparative ability of Qdm/Qa-1b, kb, and Db to protect class Ilow cells from NK-mediated lysis in vivo

31 March 2020

1 reference

Expression of stress-induced MHC class I related chain molecules on human melanoma

31 March 2020

1 reference

Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer

31 March 2020

1 reference

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

31 March 2020

1 reference

CD27-mediated activation of murine NK cells

31 March 2020

1 reference

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

31 March 2020

1 reference

2B4 functions as a co-receptor in human NK cell activation

31 March 2020

1 reference

Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12

31 March 2020

1 reference

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

31 March 2020

1 reference

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

31 March 2020

1 reference

Flt3 ligand induces tumor regression and antitumor immune responses in vivo

31 March 2020

1 reference

In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice

31 March 2020

1 reference

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity

31 March 2020

1 reference

Expression and regulation of chemokine receptors in human natural killer cells

31 March 2020

1 reference

Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy

31 March 2020

1 reference

Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer

31 March 2020

1 reference

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer

31 March 2020

1 reference

Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma

31 March 2020

1 reference

Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease

31 March 2020

1 reference

Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibody

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC928

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference